The results indicated that Runyan Mixture may play a role in the treatment of pharyngitis mainly by acting on core targets, such as EGFR, MAPK1, AKT1, PIK3CA, NFKB1, SRC, TNF, MAPK8, MET, and PTGS2. This evidence concerns the gene MET and pharyngitis.